Welcome to our dedicated page for Nextgen Healthcare news (Ticker: NXGN), a resource for investors and traders seeking the latest updates and insights on Nextgen Healthcare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nextgen Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nextgen Healthcare's position in the market.
NextGen Healthcare (NASDAQ: NXGN) reported preliminary unaudited fiscal 2022 fourth quarter revenue of $150 to $152 million, up from $144.2 million last year. Record bookings reached approximately $41 million. For the entire fiscal year 2022, revenue is projected at $595 to $597 million, compared to $556.8 million in fiscal 2021. However, net income per share is expected to decline to $0.01-$0.03 from $0.14 last year. The company introduced fiscal 2023 guidance, forecasting revenue between $628-$640 million and non-GAAP EPS of $0.95-$1.01.
NextGen Healthcare (NASDAQ: NXGN) announced it will release its fiscal 2022 fourth quarter and full-year results after market close on May 17, 2022. A conference call will follow at 5:00 p.m. ET. Interested participants can join the call by dialing 866-831-8713 or 203-518-9822 for international callers. The company provides innovative healthcare technology solutions aimed at enhancing clinical quality and financial performance for healthcare providers. More details can be found on their investor relations website.
Summary not available.
NextGen Healthcare (NASDAQ: NXGN) will host its 2022 Investor Event on May 3, 2022, from 10:00 a.m. to 12:00 p.m. at the Nasdaq MarketSite in New York City. The event, featuring key executives including CEO David Sides and CFO Jamie Arnold, will be available for live broadcast. Interested investors can register online. NextGen Healthcare focuses on cloud-based technology solutions for ambulatory care, aiming to enhance healthcare outcomes through integrated services.
NextGen Healthcare has launched the NextGen Behavioral Health Suite, an integrated electronic health record (EHR) platform designed to enhance comprehensive primary care and behavioral health for individuals with intellectual and developmental disabilities (I/DD). This first-of-its-kind solution features improved workflows, expanded reporting capabilities, and support for outpatient mental health services. Key updates include documenting care for clients with I/DD, residential treatment functionalities, and enhanced electronic visit verification to promote better outcomes in healthcare delivery.
Summary not available.
NextGen Healthcare, Inc. (NASDAQ: NXGN) has partnered with Paralympic medalist Amy Purdy to promote its #NextGenMind campaign, focusing on the connection between mental and physical health. This initiative aims to enhance whole-person care through advanced technology solutions. The partnership was inaugurated with a media tour and a public event featuring discussions on mental health resources. With rising mental health issues due to the pandemic, the campaign targets youth, emphasizing the importance of mental wellness in overall health.
Summary not available.
NextGen Healthcare (NASDAQ: NXGN) is showcasing its innovations at HIMSS22 in Orlando, Florida, from March 14-18. The company will demonstrate its NextGen® Enterprise EHR, the first in the industry to achieve the ONC-Health IT 2015 Edition Cures Update Certification. Highlights include discussions on interoperability, integrated health solutions, and patient experience enhancements. Key features include NextGen® Mobile and support for remote patient monitoring, demonstrating NextGen's commitment to improving healthcare outcomes through advanced technology.
NextGen Healthcare (Nasdaq: NXGN), a leader in cloud-based technology solutions, announced that its NextGen® Enterprise EHR is the first complete EHR to receive the ONC-Health IT 2015 Edition Cures Update certification from Drummond Group LLC. This certification confirms the software's ability to help eligible clinicians comply with regulatory programs and interoperability standards mandated by the 21st Century Cures Act. CEO David Sides emphasized the achievement's significance for improving patient care and meeting stringent government regulations.